206 related articles for article (PubMed ID: 1373460)
1. Effect of combination chemotherapy with cefoperazone on non-Hodgkin's lymphoma.
Natazuka T; Matsui T; Ito M; Sugimoto T; Nakao Y; Fujita T
Leuk Res; 1992; 16(4):417-8. PubMed ID: 1373460
[No Abstract] [Full Text] [Related]
2. Rituximab in combination with interferon-alpha in relapsed and refractory diffuse large B-cell non-Hodgkin's lymphoma.
Bertè R; Vallisa D; Civardi G; Moroni CF; Lazzaro A; Cavanna L
Acta Haematol; 2001; 106(3):141-2. PubMed ID: 11713384
[No Abstract] [Full Text] [Related]
3. [Treatment of primary mediastinal large B-cell lymphomas].
Schneider T; Tóth E; Molnár Z; Várady E; Deák B; Horváth A; Horváth GI; Eid H; Schneider K; Lovey J; Keresztes S; Esik O; Lengyel Z; Rosta A
Orv Hetil; 2004 Dec; 145(50):2531-7. PubMed ID: 15662753
[TBL] [Abstract][Full Text] [Related]
4. Bilateral hard palate masses.
Schaberg SJ; Daniels CA; Loomer L; Addante RR
J Oral Maxillofac Surg; 1993 Nov; 51(11):1262-7. PubMed ID: 7693900
[No Abstract] [Full Text] [Related]
5. CHOP versus intensive regimens in non-Hodgkin's lymphoma.
Longo DL; DeVita VT; Young RC
N Engl J Med; 1993 Aug; 329(8):580-1; author reply 581-2. PubMed ID: 7687747
[No Abstract] [Full Text] [Related]
6. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma.
Fisher RI; Gaynor ER; Dahlberg S; Oken MM; Grogan TM; Mize EM; Glick JH; Coltman CA; Miller TP
N Engl J Med; 1993 Apr; 328(14):1002-6. PubMed ID: 7680764
[TBL] [Abstract][Full Text] [Related]
7. Results of CHOP chemotherapy for diffuse large B-cell lymphoma.
Hallack Neto AE; Pereira J; Beitler B; Chamone DA; Llacer PD; Dulley FL; Macedo MC; Chaoubah A
Braz J Med Biol Res; 2006 Oct; 39(10):1315-22. PubMed ID: 16906323
[TBL] [Abstract][Full Text] [Related]
8. [Non-Hodgkin's lymphomas: recent achievements and therapeutic perspectives].
Bron D; Vandenheule B; Stryckmans P
Rev Med Brux; 1985 Sep; 6(7):491-5. PubMed ID: 2417298
[No Abstract] [Full Text] [Related]
9. ProMACE-CytaBOM: combination chemotherapy for diffuse large cell lymphoma.
Prokocimer M; Modan M; Rusoshansky S; Bairey O; Shaklai M
Anticancer Res; 1989; 9(4):1233-5. PubMed ID: 2479327
[TBL] [Abstract][Full Text] [Related]
10. [Chylothorax resulting from malignant non Hodgkin's lymphoma].
Ohyama S; Bando K; Hasegawa Y; Taniguti M; Shirayma H
Nihon Kokyuki Gakkai Zasshi; 1998 May; 36(5):473-7. PubMed ID: 9742867
[TBL] [Abstract][Full Text] [Related]
11. Unfavorable histologies of non-Hodgkin's lymphoma treated with ProMACE-CytaBOM: a groupwide Southwest Oncology Group study.
Miller TP; Dahlberg S; Weick JK; Files JC; Eyre HJ; Pendergrass KB; Fisher RI
J Clin Oncol; 1990 Dec; 8(12):1951-8. PubMed ID: 1700079
[TBL] [Abstract][Full Text] [Related]
12. Two cases of fatal bleomycin pneumonitis complicating the treatment of non-Hodgkin's lymphoma.
Bloor AJ; Seale JR; Marcus RE
Clin Lab Haematol; 1998 Apr; 20(2):119-21. PubMed ID: 9681223
[TBL] [Abstract][Full Text] [Related]
13. Clinical relevance of the lung resistance protein in diffuse large B-cell lymphomas.
Filipits M; Jaeger U; Simonitsch I; Chizzali-Bonfadin C; Heinzl H; Pirker R
Clin Cancer Res; 2000 Sep; 6(9):3417-23. PubMed ID: 10999723
[TBL] [Abstract][Full Text] [Related]
14. [THP-COP, BHAC-VMP alternating chemotherapy in patients with non-Hodgkin's lymphoma].
Imura H; Ito N; Shirakawa S; Sobue R; Maruyama F; Kojima H; Shinkai K; Matsui T; Ino T; Shimizu K
Rinsho Ketsueki; 1988 May; 29(5):688-93. PubMed ID: 3216495
[No Abstract] [Full Text] [Related]
15. Rituximab in heavily pretreated cutaneous B-cell lymphoma.
Zinzani PL; Stefoni V; Alinari L; Vianelli N; Baccarani M
Leuk Lymphoma; 2003 Sep; 44(9):1637-8. PubMed ID: 14565673
[No Abstract] [Full Text] [Related]
16. Lactic Acidosis in Non-Hodgkin's Lymphoma and response to Chemotherapy.
Osorio S; Bernis C; de La Cámara R
Haematologica; 2002 Feb; 87(2):ELT05. PubMed ID: 11836182
[No Abstract] [Full Text] [Related]
17. Tailored chemotherapy for malignant lymphoma arising in the setting of posttransplant lymphoproliferative disorder after solid organ transplantation.
Watts RG; Hilliard LM; Berkow RL
J Pediatr Hematol Oncol; 2002 Nov; 24(8):622-6. PubMed ID: 12439033
[TBL] [Abstract][Full Text] [Related]
18. Randomized study comparing doxorubicin, cyclophosphamide, vincristine, methotrexate with leucovorin rescue, and cytarabine (ACOMLA) with cyclophosphamide, doxorubicin, vincristine, prednisone, and bleomycin (CHOP-B) in the treatment of diffuse histiocytic lymphoma.
Newcomer LN; Cadman EC; Nerenberg MI; Chen M; Bertino JR; Farber LR; Prosnitz LR
Cancer Treat Rep; 1982 Jun; 66(6):1279-84. PubMed ID: 6177407
[TBL] [Abstract][Full Text] [Related]
19. [A case of diffuse large cell lymphoma treated with combination chemotherapy of CHOP (cyclophosphamide, doxorubicin, vincristine, prednisolone) and BEMP (bleomycin, etoposide, mitoxantrone, procarbazine) with complete remission].
Itoh T; Sakata Y; Suzuki H; Sugimoto N; Sohma N; Kishibe T; Higuchi S; Seino Y
Gan To Kagaku Ryoho; 1992 Feb; 19(2):241-4. PubMed ID: 1371049
[TBL] [Abstract][Full Text] [Related]
20. Southwest Oncology Group clinical trials for intermediate- and high-grade non-Hodgkin's lymphomas.
Miller TP; Dana BW; Weick JK; Jones SE; Coltman CA; Dahlberg S; Fisher RI
Semin Hematol; 1988 Apr; 25(2 Suppl 2):17-22. PubMed ID: 2456619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
